{"gao_id": "GAO-25-106774", "published": "2024-11-18T12:00:00Z", "released": "2024-11-18T07:00:00Z", "summary": "Millions of Americans\u2014many of them children\u2014have a rare disease. But only about 5% of the nearly 10,000 identified rare diseases have Food and Drug Administration-approved treatments. Developing rare disease drugs is challenging. The diseases aren't well understood, and small patient populations can limit clinical trial results. FDA has 18 rare disease programs to address such complexities. FDA is also implementing a new Rare Disease Innovation...", "title": "Rare Disease Drugs: FDA Has Steps Underway to Strengthen Coordination of Activities Supporting Drug Development", "topics": ["Agency evaluations", "Patient care", "Diseases", "Biologics", "Prescription drugs", "Health Care", "Biological products", "Precious metals", "Blood", "Clinical trials", "Drugs"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-25-106774", "versions": [{"title": "View Full Report Online", "url": "https://files.gao.gov/reports/GAO-25-106774/index.html"}, {"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-25-106774-highlights.pdf"}, {"title": "Full Report (63 pages)", "url": "https://www.gao.gov/assets/gao-25-106774.pdf"}]}